ArticleLeukemia2026

Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications.

Jonas Schadt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.